Valerenic acid ameliorates amphetamine-related neurotoxicity by improving hypothalamus tyrosine hydroxylase and histamine-N-methyl transferase enzymes
Background: Narcolepsy, obesity, and attention deficit hyperactivity disorder are all treated with amphetamine (a central nervous system stimulant) while valerenic acid (VA) has a pharmacological effect in the central nervous system. Objectives: The purpose of this study was to ascertain whether VA...
Saved in:
Main Authors: | Khaled M.M. Koriem, Ammar H.A. Naiem |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-06-01
|
Series: | Toxicology Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S221475002500054X |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Tyrosine hydroxylase of the brain and it’s regulation by glucocorticoids
by: E. V. Sukhareva, et al.
Published: (2016-05-01) -
Valerenic acid attenuates pathological myocardial hypertrophy by promoting the utilization of multiple substrates in the mitochondrial energy metabolism
by: Tiantian Liu, et al.
Published: (2025-02-01) -
Current and future perspectives on clinical management of classic 21-hydroxylase deficiency
by: Analia Yogi, et al.
Published: (2023-10-01) -
Expression of catecholaminergic genes in the midbrain and prepulse inhibition in rats with a genetic catatonia
by: M. A. Ryazanova, et al.
Published: (2017-12-01) -
Induction of tyrosine aminotransferase in mice is inhibited by activated metabolites of ortho- aminoazotoluene
by: V. I. Kaledin, et al.
Published: (2015-07-01)